Because OT1 TILs did not express the IL-33 receptor ST2, the contribution of secreted IL-33 must be CD8+ T-cell extrinsic, likely due to its ability to reprogram the TME12 and activate tumor-associated dendritic cells to restore their cross-priming potential12. The gene discussed is IL33; the disease is neoplasm.